Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 382

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples

Open access
Northcott, Paul A., Shih, David J. H., Remke, Marc, Cho, Yoon-Jae, Kool, Marcel, Hawkins, Cynthia, Eberhart, Charles G., Dubuc, Adrian, Guettouche, Toumy, Cardentey, Yoslayma, Bouffet, Eric, Pomeroy, Scott L., Marra, Marco, Malkin, David, Rutka, James T., Korshunov, Andrey, Pfister, Stefan, Taylor, Michael D. · 2012 · Acta Neuropathologica

Abstract

The diagnosis of medulloblastoma likely encompasses several distinct entities, with recent evidence for the existence of at least four unique molecular subgroups that exhibit distinct genetic, transcriptional, demographic, and clinical features. Assignment of molecular subgroup through routine profiling of high-quality RNA on expression microarrays is likely impractical in the clinical setting. The planning and execution of medulloblastoma clinical trials that stratify by subgroup, or which are targeted to a specific subgroup requires technologies that can be economically, rapidly, reliably, and reproducibly applied to formalin-fixed paraffin embedded (FFPE) specimens. In the current study, we have developed an assay that accurately measures the expression level of 22 medulloblastoma subgroup-specific signature genes (CodeSet) using nanoString nCounter Technology. Comparison of the nanoString assay with Affymetrix expression array data on a training series of 101 medulloblastomas of known subgroup demonstrated a high concordance (Pearson correlation r = 0.86). The assay was validated on a second set of 130 non-overlapping medulloblastomas of known subgroup, correctly assigning 98% (127/130) of tumors to the appropriate subgroup. Reproducibility was demonstrated by repeating the assay in three independent laboratories in Canada, the United States, and Switzerland. Finally, the nanoString assay could confidently predict subgroup in 88% of recent FFPE cases, of which 100% had accurate subgroup assignment. We present an assay based on nanoString technology that is capable of rapidly, reliably, and reproducibly assigning clinical FFPE medulloblastoma samples to their molecular subgroup, and which is highly suited for future medulloblastoma clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-011-0899-7

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 382

Metadata

Authors
Northcott, P. A., Shih, D. J. H., Remke, M., Cho, Y.-J., Kool, M., Hawkins, C., Eberhart, C. G., Dubuc, A., Guettouche, T., Cardentey, Y., Bouffet, E., Pomeroy, S. L., Marra, M., Malkin, D., Rutka, J. T., Korshunov, A., Pfister, S., & Taylor, M. D.
Venue
Acta Neuropathologica
Published
2011-11-06
Volume
123
Issue
4
Pages
615-626
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W1996409634
Cited by
382
References
18
FWCI
10.83
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. https://app.cochat.ai/papers/10.1007/s00401-011-0899-7
The paper
Northcott, P. A., Shih, D. J. H., Remke, M., Cho, Y.-J., Kool, M., Hawkins, C., Eberhart, C. G., Dubuc, A., Guettouche, T., Cardentey, Y., Bouffet, E., Pomeroy, S. L., Marra, M., Malkin, D., Rutka, J. T., Korshunov, A., Pfister, S., & Taylor, M. D. (2012). Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathologica. https://doi.org/10.1007/s00401-011-0899-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.